| Report period | 2018 | 2019 | 2020 | 2021 | 2022 | Q1 23 |
|---|---|---|---|---|---|---|
| End date of the reporting period | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Capitalization, $ | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Capitalization, $ | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Enterprise Value | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Book Value | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Shareholders Book Value | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Current liabilities | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Noncurrent liabilities | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Total liabilities | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Debt | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Cash and cash equivalents | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Net debt | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Assets | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Total ordinary shares | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Ordinary share price | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
| Ticker | Name | Type | Nominal value | ISIN | Price |
|---|---|---|---|---|---|
| MET:US | MetLife Inc. | Common share | - | US59156R1086 | $81.02 |
| Date | Type | Note | Source |
|---|---|---|---|
| 09.12.2025 10:00 | Dividends | The company will pay dividends of $0.5675 per common share for Q4 Fiscal Year 2025. | www.metlife.com |
investor.metlife.com
metlife.com
investor.metlife.com
investor.metlife.com| Company name | MetLife |
|---|---|
| Tags | #s&p500 index |
| Sector | Financials / Insurance / Insurance / Life & Health Insurance |
| Business address | 200 PARK AVENUE NEW YORK NY 10166 212-578-5500 |
| Mailing address | 200 PARK AVENUE NEW YORK NY 10166 |
| Website | investor.metlife.com |
| Information disclosure | www.sec.gov |